Inverto Group Research
Diagnostic intelligence for clinical-stage operators and capital allocators.
Issues are released when the underlying data warrants publication, not on a calendar.
Issues
- Issue No. 1By Milos Rogic · May 2026
The Runway Illusion: Why Clinical-Stage Biotech CFOs Are Systematically Under-Modeling Their Path to Readout
Phase 2 trials structurally require 30–39 months to readout. Most CFOs are running 18-month runway models against them. The gap is not a planning error — it is a category error.
Read issue → - Issue No. 2Forthcoming
In preparation.